Chemical pollutant linked to risk of cancer in males
the ONA take:
According to new findings published in the journal Science of the Total Environment, researchers from the University of Granada in Granada, Spain, have found that exposure to a chemical pollutant known as PCB-153 is positively linked to the risk of cancer in males. This agent can still be found in some fat-rich foods, particularly large, fat-rich fish.
For the study, researchers analyzed the accumulated levels of various pollutants in the body fat of 268 adults and identified those who developed cancer over a 9-year period.
Results showed that the accumulated exposure of PCB-153 was positively associated with the risk of cancer among men.
PCB-153 is part of a group of chemicals widely used in various types of industrial equipment. Because of its high resistance to degradation, the researchers suggest that fat food is the main source of exposure to the chemical pollutant. A fat-rich diet may be the cause of high PCB levels.
The researchers also hypothesize that the pollutant could interact with hormone receptors, produce free radicals, or alter DNA, thus causing cancer.
Exposure to a chemical pollutant known as PCB-153 is positively linked to the risk of cancer in males.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|